Serina Therapeutics, Inc.
SER
$3.81
-$0.09-2.31%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 15.83% | 6.81% | |||
| Gross Profit | -20.81% | -2.41% | |||
| SG&A Expenses | 7.79% | -12.52% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.24% | -2.78% | |||
| Operating Income | -14.86% | 5.00% | |||
| Income Before Tax | 28.89% | -34.01% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.89% | -34.01% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -28.57% | 55.56% | |||
| Net Income | 28.89% | -33.97% | |||
| EBIT | -14.86% | 5.00% | |||
| EBITDA | -14.90% | 5.00% | |||
| EPS Basic | 30.94% | -33.02% | |||
| Normalized Basic EPS | 31.20% | -30.62% | |||
| EPS Diluted | 31.33% | -33.79% | |||
| Normalized Diluted EPS | 31.20% | -30.62% | |||
| Average Basic Shares Outstanding | 3.35% | 2.54% | |||
| Average Diluted Shares Outstanding | 3.35% | 2.54% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||